Related Experiment Video
Updated: Aug 25, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Genome-wide identification of genetic modifiers of Pak1-dependent skin tumor susceptibility in mice
Kazuhiro Okumura1, Megumi Saito1, Keisuke Otoyama1
1Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute.
Abstract:
Pak1, a serine/threonine kinase, plays dual roles during the tumor progression and immune response. Unfortunately, the genetic modifiers underlying the resistance caused by Pak1 deficiency in CD11c-positive immune cells have been poorly defined so far. To adequately address this gap, we conducted a forward genetic screen using Cd11cCre-Pak1fl/+ F1 backcross mice (n=182). GRAS-Di-based genome-wide genotyping has identified 14,053 high-confidence markers, and we analyzed them by taking advantage of the principal component-adjusted generalized linear models (GLMs). Among the nine candidates of genome-wide significant Pak1 modifier loci (Pm1-Pm9) associated with tumor susceptibility, Pm1 on chromosome 5 showed the earliest and strongest association with the stages of papilloma and carcinoma. Intriguingly, epistasis analysis revealed that Pm3 on chromosome 4 attenuates the tumor-promoting effect of Pm1 in an allele-dependent manner, raising a possibility that the immune regulators modulate tumor susceptibility in Pak1-reduced immune compartment. Taken together, our present findings delineate a genetic framework implicated in Pm1/Pm3 axis during Pak1-reduced, skin carcinogenesis driven by immune response.
Insights
Researchers identified genetic modifiers affecting skin tumor susceptibility in mice with reduced Pak1 in immune cells. Key loci, Pm1 and Pm3, interact to influence tumor development, revealing a genetic framework for immune-mediated carcinogenesis.
Area of Science:
- Immunology
- Genetics
- Oncology
Background:
- Pak1 (p21-activated kinase 1) is a kinase involved in tumor progression and immune responses.
- Genetic modifiers of resistance due to Pak1 deficiency in CD11c-positive immune cells are not well understood.
Purpose of the Study:
- To identify genetic modifiers influencing tumor susceptibility in mice with Pak1-deficient immune cells.
- To elucidate the genetic framework underlying immune-mediated skin carcinogenesis.
Main Methods:
- A forward genetic screen was performed using Cd11cCre-Pak1fl/+ F1 backcross mice.
- Genome-wide genotyping with GRAS-Di identified 14,053 markers.
- Principal component-adjusted generalized linear models (GLMs) were used for analysis.
Main Results:
- Nine genome-wide significant Pak1 modifier loci (Pm1-Pm9) associated with tumor susceptibility were identified.
- Pm1 on chromosome 5 showed the strongest association with papilloma and carcinoma.
- Epistasis analysis revealed Pm3 on chromosome 4 attenuates Pm1's tumor-promoting effect.
Conclusions:
- A genetic framework involving the Pm1/Pm3 axis in Pak1-reduced skin carcinogenesis was delineated.
- Immune regulators modulate tumor susceptibility in a Pak1-reduced immune compartment.
- Findings highlight the interplay between immune cells and genetic factors in cancer development.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Pleiotropy
